Most Recent
‘Horse has bolted’: Judge declasses COVID-19 insurance class actions
Four proceedings over COVID-19 business interruption losses will be stripped of class action status, with a judge saying most of the common issues were already determined in test cases.
AFL concussion class action adds Geelong Football Club as defendant
A class action on behalf of AFL players who allegedly suffered brain injuries has added plaintiff Max Rooke's former club to the case, and plans to file a separate action against the remaining clubs.
CBA class actions win halt to costs battle pending appeal
Applicants in two dismissed class actions against the Commonwealth Bank have secured an order staying an assessment of costs in the failed cases until the outcome of an appeal.
Super Retail hit with second Fair Work case in Federal Court
Super Retail faces a second Federal Court case by a former senior female executive, after conciliation proceedings in the Fair Work Commission failed to resolve the complaint.
Captain Cook, ACCC to mediate after failed High Court appeal
Captain Cook College and its COO will attempt to reach an agreement on penalty with the ACCC after the High Court knocked back their appeal of a systemic unconscionable conduct finding.
Advanta Seeds can’t force licensee Nuseed to fix seed labels
The developer of a Canola seed hybrid tolerant to herbicide has lost a bid for seed grower Nuseed to relabel its products, which are already stocked in 361 retail locations.
Justin Hemmes’ Establishment wins trade mark spat with restaurant
Sydney hospitality mogul Justin Hemmes has prevailed in a trade mark stoush with Brisbane restaurant Establishment 203.
Insurers on hook for Opal Tower class action costs after failed appeal
Two insurers have come up short in their appeal of a ruling that put them on the hook for the costs of Opal Tower consultant engineer WSP in a class action by residents.
No ‘bottomless pit’: Class action administrator put on notice about costs
An administrator has won $1 million more in costs for distributing a class action settlement, but a judge warned any ‘overshoot’ might not be borne by group members.
Lundbeck wins appeal in decade-long IP battle with Sandoz over Lexapro
Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.